Brian J. Werth

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Brian J. Werth, George Sakoulas, Warren E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2012 · 135 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics

Kelly M. Hines, Adam Waalkes, Kelsi Penewit et al. · mSphere · 2017 · 123 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen

Brian J. Werth, Rupali Jain, Andrew W. Hahn et al. · Clinical Microbiology and Infection · 2017 · 100 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

Cheryl Mather, Brian J. Werth, Shobini Sivagnanam et al. · Journal of Clinical Microbiology · 2016 · 79 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey

Jeremiah Seni, Siana Mapunjo, Rachel Wittenauer et al. · BMJ Open · 2020 · 79 citations · Full text

Pharmacy, Hospital Pharmacy, Antimicrobial Pharmacotherapy +13